(Q79791604)
Statements
A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata (English)
Kristof Chwalisz
Lois Larsen
Cynthia Mattia-Goldberg
Anthony Edmonds
Walter Elger
20 February 2007